Intraperitoneal chemotherapy for peritoneal metastases: pharmacokinetic rationale, evidence by tumor site and toxicity
Intraperitoneal chemotherapy exploits the peritoneal–plasma barrier: drugs given into the cavity reach the peritoneal surface at concentrations many times higher than in